Australia markets closed

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.2500+0.0400 (+1.25%)
At close: 04:00PM EDT
3.3500 +0.05 (+1.52%)
Pre-market: 08:34AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-1.1-0.84-3.5-2.22
Low estimate-1.25-0.95-3.83-2.59
High estimate-0.95-0.73-3.17-1.85
Year ago EPS-0.77-0.16-2.46-3.5
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-5.04-1.01-0.86-0.78
Actual EPS-0.77-0.16-0.72-2.28
Difference4.270.850.14-1.5
Surprise %84.70%84.20%16.30%-192.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.1-0.84-3.5-2.22
7 days ago-1.1-0.84-3.5-2.22
30 days ago-0.96-0.89-3.26-2.49
60 days ago-0.96-0.89-3.26-2.49
90 days ago-0.96-0.9-3.26-2.49
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesNRBOIndustrySector(s)S&P 500
Current qtr.-42.90%N/AN/AN/A
Next qtr.-425.00%N/AN/AN/A
Current year-42.30%N/AN/AN/A
Next year36.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A